Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine's Oral Candidate for Rapid Relief of Depression
SALT LAKE CITY, May 16, 202. Lipocine Inc. today announced positive topline results from a pilot clinical PK bridge study of LPCN 1154 (oral brexanolone) with a comparator, IV brexanolone. The pilot study is an important step in Lipocine ' s ongoing... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 16, 2023 Category: Pharmaceuticals Source Type: clinical trials

The Evaluation of Balanced Salt Solution During Cataract Surgery
Conditions:   Fuchs Dystrophy;   Cataract Interventions:   Drug: BSS Plus;   Drug: BSS Sponsors:   Adam Fedyk, MD, FACS;   Alcon Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2023 Category: Research Source Type: clinical trials

The Evaluation of Balanced Salt Solution During Cataract Surgery
Conditions:   Fuchs Dystrophy;   Cataract Interventions:   Drug: BSS Plus;   Drug: BSS Sponsors:   Adam Fedyk, MD, FACS;   Alcon Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2023 Category: Research Source Type: clinical trials